Read-Gene S.A. (WSE:RDG)
5.32
-0.16 (-2.92%)
At close: Dec 5, 2025
Read-Gene Revenue
Read-Gene had revenue of 3.39M PLN in the quarter ending September 30, 2025, with 1.95% growth. This brings the company's revenue in the last twelve months to 15.19M, up 19.91% year-over-year. In the year 2024, Read-Gene had annual revenue of 13.23M with 30.38% growth.
Revenue (ttm)
15.19M
Revenue Growth
+19.91%
P/S Ratio
4.13
Revenue / Employee
759.69K
Employees
30
Market Cap
62.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.23M | 3.08M | 30.38% |
| Dec 31, 2023 | 10.15M | 2.91M | 40.14% |
| Dec 31, 2022 | 7.24M | 787.35K | 12.20% |
| Dec 31, 2021 | 6.45M | 384.57K | 6.34% |
| Dec 31, 2020 | 6.07M | -296.62K | -4.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |